1. Home
  2. ABT vs APP Comparison

ABT vs APP Comparison

Compare ABT & APP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ABT

Abbott Laboratories

HOLD

Current Price

$82.44

Market Cap

183.3B

Sector

Health Care

ML Signal

HOLD

Logo Applovin Corporation

APP

Applovin Corporation

HOLD

Current Price

$462.41

Market Cap

150.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABT
APP
Founded
1888
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
183.3B
150.7B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
ABT
APP
Price
$82.44
$462.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
20
18
Target Price
$130.90
$694.44
AVG Volume (30 Days)
12.1M
3.9M
Earning Date
04-16-2026
05-06-2026
Dividend Yield
2.76%
N/A
EPS Growth
N/A
115.23
EPS
0.61
3.56
Revenue
$44,328,000,000.00
$5,480,717,000.00
Revenue This Year
$10.75
$47.88
Revenue Next Year
$8.10
$29.14
P/E Ratio
$138.06
$131.41
Revenue Growth
5.67
16.38
52 Week Low
$84.20
$321.68
52 Week High
$137.49
$745.61

Technical Indicators

Market Signals
Indicator
ABT
APP
Relative Strength Index (RSI) 19.83 51.94
Support Level N/A $367.12
Resistance Level $112.81 $479.56
Average True Range (ATR) 2.01 26.08
MACD -0.47 0.89
Stochastic Oscillator 1.48 40.18

Price Performance

Historical Comparison
ABT
APP

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

About APP Applovin Corporation

AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.

Share on Social Networks: